Similar articles

• [Progress in adjuvant therapy for colorectal cancer].

  Kohnoe S, Kakeji Y, Maehara Y. Kohnoe S, et al. Gan To Kagaku Ryoho. 2002 Dec;29(13):2488-97. Gan To Kagaku Ryoho. 2002. PMID: 12506471 Review. Japanese.
• Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin.

  Tsunoda A, Nakao K, Watanabe M, Matsui N, Tsunoda Y. Tsunoda A, et al. Jpn J Clin Oncol. 2010 May;40(5):412-9. doi: 10.1093/jjco/hyp185. Epub 2010 Jan 18. Jpn J Clin Oncol. 2010. PMID: 20085907
• UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.

  Hoff PM, Pazdur R, Benner SE, Canetta R. Hoff PM, et al. Anticancer Drugs. 1998 Jul;9(6):479-90. Anticancer Drugs. 1998. PMID: 9877235 Review.
• [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].

  Kodaira S, Shatari T, Nozawa K. Kodaira S, et al. Gan To Kagaku Ryoho. 2000 Dec;27(14):2201-8. Gan To Kagaku Ryoho. 2000. PMID: 11142163 Review. Japanese.
• Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.

  [No authors listed] [No authors listed] Prescrire Int. 2002 Apr;11(58):44-7. Prescrire Int. 2002. PMID: 11987311